Cvrx share price today

(CVRX)

Cvrx share price is $13.47 & ₹1,155.86 as on 7 Jan 2025, 2.30 'hrs' IST

$13.47

▲

-0.17

(-1.25%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Cvrx share price in Dollar and Rupees. Guide to invest in Cvrx stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cvrx, along with analyst recommendations, forecasts, and comprehensive financials.

Cvrx share price movements

Today's Low: $13.33
Today's High: $14.01
$13.47
1.04%
Downside
Day's Volatility :4.85%
Upside
3.85%
52 Weeks Low: $6.40
52 Weeks High: $30.38
$13.47
52.49%
Downside
52 Weeks Volatility :78.93%
Upside
55.66%

Cvrx Returns

Period	Cvrx Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	62.77%	-8.4%	0.0%
6 Months	17.28%	-3.8%	0.0%
1 Year	-51.34%	-0.1%	0.0%
3 Years	47.14%	2.9%	-19.8%

Cvrx Key Statistics

in dollars & INR

Previous Close	$13.64
Open	$13.67
Today's High	$14.01
Today's Low	$13.33
Market Capitalization	$307.4M
Today's Volume	$99.3K
52 Week High	$30.38
52 Week Low	$6.4
Revenue TTM	$47.3M
EBITDA	$-58.3M
Earnings Per Share (EPS)	$-2.69
Profit Margin	-123.75%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-79.02%

How to invest in Cvrx from India?

It is very easy for Indian residents to invest directly in Cvrx from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cvrx stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cvrx or CVRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cvrx or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cvrx shares which would translate to 0.064 fractional shares of Cvrx as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cvrx, in just a few clicks!

Returns in Cvrx for Indian investors in Rupees

Investment Value

₹1,00,000

Cvrx investment value today

Current value as on today

₹51,278

Returns

₹48,722

(-48.72%)

Returns from Cvrx Stock

₹51,944 (-51.94%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Cvrx

64%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Cvrx on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 64% more investors are searching Cvrx in the last 30 days versus the previous period.

Global Institutional Holdings in Cvrx

Johnson & Johnson
16.91%
NEA Management Company, LLC
9.77%
BlackRock Inc
3.61%
Vanguard Group Inc
3.40%
Parkman Healthcare Partners LLC
2.81%
Schonfeld Strategic Advisors LLC
2.25%

Analyst Recommendation on Cvrx

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Cvrx(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Cvrx

What analysts predicted

Upside of 34.87%

Current:

$13.47

Target:

$18.17

Insights on Cvrx

Price Movement
In the last 3 months, CVRX stock has moved up by 55.4%
Increasing Revenue
Revenue is up for the last 3 quarters, 10.77M → 13.37M (in $), with an average increase of 10.3% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -22.18M → -13.09M (in $), with an average increase of 32.6% per quarter
CVRX vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 55.9% return, outperforming this stock by 109.8%
CVRX vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 112.9% return, outperforming this stock by 87.8%
Price to Sales
ForCVRX every $1 of sales, investors are willing to pay $6.2, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Cvrx Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$6.3M	-
Net Income	$-14.6M	-
Net Profit Margin	-233.87%	-

	FY20	Y/Y Change
Revenue	$6.1M	↓ 3.26%
Net Income	$-14.1M	↓ 3.58%
Net Profit Margin	-233.09%	↑ 0.78%

	FY21	Y/Y Change
Revenue	$13.0M	↑ 115.36%
Net Income	$-43.1M	↑ 205.32%
Net Profit Margin	-330.45%	↓ 97.36%

	FY22	Y/Y Change
Revenue	$22.5M	↑ 72.36%
Net Income	$-41.4M	↓ 3.83%
Net Profit Margin	-184.38%	↑ 146.07%

	FY23	Y/Y Change
Revenue	$39.3M	↑ 74.89%
Net Income	$-41.2M	↓ 0.55%
Net Profit Margin	-104.85%	↑ 79.53%

	Q2 FY23	Q/Q Change
Revenue	$9.5M	↑ 19.06%
Net Income	$-11.7M	↑ 2.44%
Net Profit Margin	-122.64%	↑ 19.91%

	Q3 FY23	Q/Q Change
Revenue	$10.5M	↑ 10.64%
Net Income	$-9.0M	↓ 22.66%
Net Profit Margin	-85.73%	↑ 36.91%

	Q4 FY23	Q/Q Change
Revenue	$11.3M	↑ 7.55%
Net Income	$-9.2M	↑ 1.69%
Net Profit Margin	-81.05%	↑ 4.68%

	Q1 FY24	Q/Q Change
Revenue	$10.8M	↓ 4.73%
Net Income	$-22.2M	↑ 142.13%
Net Profit Margin	-206.0%	↓ 124.95%

	Q2 FY24	Q/Q Change
Revenue	$11.8M	↑ 9.63%
Net Income	$-14.0M	↓ 36.77%
Net Profit Margin	-118.82%	↑ 87.18%

	Q3 FY24	Q/Q Change
Revenue	$13.4M	↑ 13.26%
Net Income	$-13.1M	↓ 6.63%
Net Profit Margin	-97.95%	↑ 20.87%

	FY19	Y/Y Change
Profit	$4.6M	-

	FY20	Y/Y Change
Profit	$4.6M	↑ 0.85%

	FY21	Y/Y Change
Profit	$9.4M	↑ 103.69%

	FY22	Y/Y Change
Profit	$17.5M	↑ 85.93%

	FY23	Y/Y Change
Profit	$33.0M	↑ 89.12%

	Q2 FY23	Q/Q Change
Profit	$8.0M	↑ 20.03%

	Q3 FY23	Q/Q Change
Profit	$8.8M	↑ 10.48%

	Q4 FY23	Q/Q Change
Profit	$9.6M	↑ 8.67%

	Q1 FY24	Q/Q Change
Profit	$9.0M	↓ 5.85%

	Q2 FY24	Q/Q Change
Profit	$9.8M	↑ 8.22%

	Q3 FY24	Q/Q Change
Profit	$11.1M	↑ 13.92%

	FY19	Y/Y Change
Operating Cash Flow	$-12.8M	-
Investing Cash Flow	$-106.0K	-
Financing Cash Flow	$29.5M	-

	FY20	Y/Y Change
Operating Cash Flow	$-16.1M	↑ 25.9%
Investing Cash Flow	$-311.0K	↑ 193.4%
Financing Cash Flow	$49.8M	↑ 68.48%

	FY21	Y/Y Change
Operating Cash Flow	$-27.7M	↑ 72.29%
Investing Cash Flow	$-1.2M	↑ 280.39%
Financing Cash Flow	$111.9M	↑ 124.74%

	FY22	Y/Y Change
Operating Cash Flow	$-42.7M	↑ 53.89%
Investing Cash Flow	$-685.0K	↓ 42.1%
Financing Cash Flow	$7.5M	↓ 93.3%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-12.8M	↑ 24.97%
Investing Cash Flow	$-143.0K	↓ 40.42%
Financing Cash Flow	$473.0K	↓ 93.75%

Cvrx Technicals Summary

Sell

Neutral

Buy

Cvrx is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Cvrx Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cvrx Inc	0.0%	17.28%	-51.34%	47.14%	-26.43%
Stryker Corporation	-5.14%	7.73%	20.51%	37.02%	70.83%
Boston Scientific Corp.	2.22%	18.53%	55.24%	113.84%	98.4%
Edwards Lifesciences Corp.	4.25%	-20.93%	-2.33%	-38.47%	-5.21%
Abbott Laboratories	-0.93%	11.99%	1.27%	-15.84%	31.69%
Medtronic Plc	-3.59%	5.29%	-6.49%	-23.36%	-31.62%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cvrx Inc	0.14	NA	NA	-2.57	-0.79	-0.31	NA	2.69
Stryker Corporation	38.59	38.59	2.51	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.82	73.82	1.62	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.0	28.0	6.67	2.54	0.19	0.11	NA	16.18
Abbott Laboratories	34.38	34.38	2.19	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.43	24.43	1.46	5.45	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cvrx Inc	Buy	$307.4M	-26.43%	0.14	-123.75%
Stryker Corporation	Buy	$137.3B	70.83%	38.59	16.34%
Boston Scientific Corp.	Buy	$131.6B	98.4%	73.82	11.26%
Edwards Lifesciences Corp.	Buy	$43.6B	-5.21%	28.0	65.86%
Abbott Laboratories	Buy	$196.2B	31.69%	34.38	13.99%
Medtronic Plc	Buy	$102.4B	-31.62%	24.43	12.06%

About Cvrx

cvrx is a private company located in minneapolis, minnesota. the company has developed proprietary implantable technology for the treatment of high blood pressure and heart failure. the barostim neo™ uses cvrx-patented technology that is designed to trigger the body’s own natural blood flow regulation system to treat these conditions. the barostim neo can be adjusted to meet each patient’s individual therapy needs.

Organization	Cvrx
Employees	200
CEO	Mr. Kevin Hykes
Industry	Healthcare

Management People of Cvrx

Name	Title
Mr. Kevin Hykes	President, CEO & Director
Mr. Jared Oasheim	Chief Financial Officer
Mr. Paul Verrastro	Chief Marketing & Strategy Officer
Mr. Paul Pignato	Vice President of Operations
Ms. Jonelle R. Burnham	VP & General Counsel
Ms. Tonya A. Austin SPHR	Chief Human Resources Officer
Ms. Jennifer E. Englund	Senior Vice President of Global Clinical Affairs
Dr. Philip B. Adamson M.D., M.Sc.	Chief Medical Officer
Ms. Bonnie Handke M.B.A., R.N.	Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics
Mr. Robert Allen John	Chief Revenue Officer

Important FAQs about investing in Cvrx from India :

What is Cvrx share price today?

Cvrx share price today stands at $13.47, Open: $13.67 ; Previous Close: $13.64 ; High: $14.01 ; Low: $13.33 ; 52 Week High: $30.38 ; 52 Week Low: $6.40. The stock opens at $13.67, after a previous close of $13.64. The stock reached a daily high of $14.01 and a low of $13.33, with a 52-week high of $30.38 and a 52-week low of $6.40.

Can Indians buy Cvrx shares?

Yes, Indians can invest in the Cvrx (CVRX) from India.

With INDmoney, you can buy Cvrx at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Cvrx at zero transaction cost.

How can I buy Cvrx shares from India?

It is very easy to buy Cvrx from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cvrx be purchased?

Yes, you can buy fractional shares of Cvrx with INDmoney app.

What are the documents required to start investing in Cvrx stocks?

To start investing in Cvrx, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.